The following organizations will be presenting cross-sector programs with
innovative paths to advancing their R&D:
- Addario Lung Cancer Medical Institute
- Adenoid Cystic Carcinoma Research Foundation
- ALS Therapy Development Institute
- Alzheimer's Association, Global Alzheimer's Association Interactive Network
- American Life Science Pharmaceuticals
- Cancer Immunotherapy Trials Network
- Center for Integration of Medicine and Innovative Technology
- Centre for Drug Research and Development, Cystic Fibrosis Technology Initiative
- Chordoma Foundation, InnoCentive Challenge
- Clinical Data Interchange Standards Consortium/Critical Path Institute
- Collaborative Drug Discovery
- Enlight Biosciences
- International AIDS Vaccine Initiative, Neutralizing Antibody Consortium
- Melanoma Research Alliance, Academic-Industrial Partnership Awards
- Jain Foundation
- Michael J. Fox Foundation for Parkinson's Research
- Microsoft, iPHR
- Multiple Myeloma Research Foundation, Personalized Medicine Initiative
- Nathaniel Adamczyk Foundation
- National Cancer Institute, SBIR Bridge Program
- National Institute of Neurological Disorders and Stroke, Spinal Muscular Atrophy Project
- Pfizer, Centers for Therapeutic Innovation
- QioMed
- RARE Project / PatientsLikeMe Partnership
- Sage Bionetworks, Standardized Informed Consent Protocol
- Sabin Vaccine Institute
- Stanford University School of Medicine, SPARK Program
- Taube-Koret Center, The Gladstone Institutes
- Translational Genomics Research Institute / Van Andel Research Institute
- University City Science Center
Click here for more information about the process for selecting these presentations.
The call for applications to present at Partnering for Cures 2011 is now closed. We would like to thank everyone for their submissions and interest in presenting at this year's Partnering meeting. All applications are currently being evaluated by our external review committee. We will be announcing selected presenters in September. Continue to check back for further details.
Application Criteria:
- Presenting organizations may be nonprofit foundations, pharmaceutical and/or biotechnology companies, research institutes, universities, government agencies, investors and private philanthropists; however, partnerships must include representatives from at least two of these sectors, and one of them must be a not-for-profit entity (i.e., foundation, university, or government agency)
- Partnerships should be six months old or more, and should be able to demonstrate some degree of progress against their established goals
- For the purposes of this year's event, we are particularly interested in applicants whose partnerships address one or more of the following:
| • Asset
Repurposing/Drug Repositioning |
| • Intellectual Property Management |
| • Translation/Commercialization
of Early Stage Academic Discoveries |
| • Data Sharing |
| • Clinical Trial Innovation |
- Any partner may apply, but FasterCures will only review one application per partnership
PLEASE NOTE: Selected initiatives/partnerships
will be limited to no more than two presenters each. Presenters must be paid
meeting registrants.
Evaluation Criteria:
- Degree to which partnership addresses one or more of the five issue areas listed above
- Degree to which partnership shows evidence of transformative potential
- Degree to which partnership can demonstrate progress against defined milestones [internal]
- Degree to which partnership can demonstrate having "moved the needle" on the issue/challenge it was established to address [external]
- Degree to which partnership model is scalable (or replicable) across diseases or sectors
|
|
 |
Terms Of Use // Privacy Statement
© 2011 by Partnering for Cures |
 |
 |
 |
 |
|
|